Skip to content

Agios Pharmaceuticals AGIO Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin90%+1.8pp88.3%+1.0pp87.2%-1.0pp88.2%+0.7pp87.5%-1.1pp
Operating margin-720%+154pp-873.9%+188pp-1,061.8%+67.3pp-1,129.1%+59.7pp-1,188.9%-22.4pp
Net margin-639.8%+124pp-764%
Returns
Return on equity-32.8%-2.6pp-30.2%
Return on invested capital-38.5%-3.1pp-35.4%+0.2pp-35.6%+11.0pp-46.7%-5.4pp-41.3%-4.5pp
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio14.2×+2.7×11.5×-2.4×13.8×-0.7×14.5×-4.0×18.5×+6.6×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$18.87-8.3%$20.58-6.8%$22.09-6.6%$23.64-7.4%$25.52-4.1%
Valuation
Market capitalization$1.98B+24.9%$1.59B-31.9%$2.33B+20.5%$1.94B+15.3%$1.68B-10.4%
Price / sales30×+0.6×29.4×-22.7×52.1×+4.7×47.4×+2.0×45.3×-6.0×
Price / book1.8×+0.5×1.3×-0.5×1.8×+0.4×1.4×+0.3×1.1×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Agios Pharmaceuticals's profit margins?
Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.
Where do Agios Pharmaceuticals's ratios come from?
Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.